Showing results (411-420 of 446) with videos related to

Sort By:
Pageof 45
Developmental Cell|September 23, 2020
A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart DevelopmentJennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Science Translational Medicine|March 22, 2023
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titersPete Schmidt, Kristin Narayan, Yong Li, et al.
Cell Reports|April 16, 2023
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primatesBronwyn M Gunn, Ryan P McNamara, Lianna Wood, et al.
The Journal of Infectious Diseases|July 14, 2019
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody ResponsesBronwyn M Gunn, Vicky Roy, Marcus M Karim, et al.
Communications Biology|July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement systemPhilipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Journal of Virology|December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus VaccineJ Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Contemporary Clinical Trials|September 15, 2020
The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care settingMatthew Lewis, Patty Chondros, Cathrine Mihalopoulos, et al.
The FEBS Journal|June 25, 2009
The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cellsKa-Kei Ho, Evelyn Rosivatz, Richard M Gunn, et al.
Frontiers in Immunology|June 7, 2021
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus SurvivorsDominic Paquin-Proulx, Bronwyn M Gunn, Aljawharah Alrubayyi, et al.
Immunity, Inflammation and Disease|December 11, 2024
Post-COVID immunity in patients with solid tumor or hematological malignancies treated with SARS-CoV-2 monoclonal antibodiesGilberto Sabino-Santos, Cathryn E Leggio, Sean M Litwin, et al.
Pageof 45